SAVING’ jab for severe asthma that could prevent deadly attacks with just two doses a year could be available to patients in ...
The treatment, which will be sold under the brand name Exdensur, is an “ultra-long-acting” version of a biologic treatment ...
Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...
More must be done to ensure that asthma patients get access to cutting-edge treatments, experts have said, after research ...
King's College London (KCL) has announced the development of a "game-changer" injection it says is the first new treatment for asthma attacks in more than half a century. Working with the University ...
People using beclometasone inhalers for asthma or other health conditions may want to read up on the NHS guidance for the ...
· Approximately 1.7 million people in the UK are living with chronic obstructive pulmonary disease (COPD) with around 600,000 being unaware of it (undiagnosed)1 · COPD has strong links with ...
An ‘asthma bus’ officially opened today at Chorley House, based on Lancashire Enterprise Business Park in Leyland, as it begins its journey around the UK aiming to offer vitally needed support to ...
A team of UK and US biologists believes it has found the underlying cause of asthma, and a cheap way to treat every sufferer. The culprit appears to be an overactive calcium sensing receptor (CaSR) ...
The National Institute for Health and Care Excellence (Nice) has recommended dupilumab for some patients whose asthma does not respond to conventional treatments. Asthma UK and the British Lung ...
A new ‘wonder drug’ injection for uncontrolled asthma has been approved for use on the NHS. Dupilumab has been recommended for some patients whose asthma does not respond to conventional treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback